Project Details
Description
Study C886R-US-16-040: A Field Study Investigating the Efficacy of Two Dose Levels of an Anti-IL-31 Monoclonal Antibody (IL-31 mAb) for Treatment of Allergic Dermatitis in Client-Owned Cats
| Status | Finished |
|---|---|
| Effective start/end date | 7/1/18 → 6/30/19 |
Funding
- ALCHERABIO, LLC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.